Related references
Note: Only part of the references are listed.Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategies
Nicolas P. E. Barry et al.
CHEMICAL SOCIETY REVIEWS (2012)
Osmium(VI) nitrido complexes bearing azole heterocycles: a new class of antitumor agents
Wen-Xiu Ni et al.
CHEMICAL SCIENCE (2012)
The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(II) arene anticancer complexes
Ying Fu et al.
CHEMICAL SCIENCE (2012)
Osmium(VI) complexes as a new class of potential anti-cancer agents
Wen-Xiu Ni et al.
CHEMICAL COMMUNICATIONS (2011)
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies
Carla Francisco et al.
DALTON TRANSACTIONS (2011)
Platinum Drug Distribution in Cancer Cells and Tumors
Alice V. Klein et al.
CHEMICAL REVIEWS (2009)
Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands
Raymond Wai-Yin Sun et al.
DALTON TRANSACTIONS (2009)
pH-Induced Aggregation of Gold Nanoparticles for Photothermal Cancer Therapy
Jutaek Nam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity
Anna F. A. Peacock et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Addition of carbenes to an osmium(VI) nitride complex
CF Leung et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2005)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Ruthenium antimetastatic agents
E Alessio et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Recent developments in the field of tumor-inhibiting metal complexes
M Galanski et al.
CURRENT PHARMACEUTICAL DESIGN (2003)